CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction
T cells, including both CD4+ and CD8+ T cells, play a pivotal role in mediating various inflammation and immune disorders. A long-standing challenge in T cell-based immunotherapy is to precisely inactivate or delete the pathogenic T cells in inflammation and autoimmune diseases, or to selectively ex...
Main Authors: | Tingting Li, Jie Pan, Hongqi Chen, Yongliang Fang, Yang Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383522001204 |
Similar Items
-
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
by: Tzu-Yi Chia, et al.
Published: (2024-01-01) -
Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
by: Zijian Pan, et al.
Published: (2022-03-01) -
Corrigendum: Role of the CXCL13/CXCR5 axis in autoimmune diseases
by: Zijian Pan, et al.
Published: (2022-10-01) -
Platelet SR-PSOX/CXCL16–CXCR6 Axis Influences Thrombotic Propensity and Prognosis in Coronary Artery Disease
by: Tianyun Guan, et al.
Published: (2022-09-01) -
CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma
by: Francesca Lepore, et al.
Published: (2018-11-01)